P1

Ofatumumab versus Teriflunomide in Multiple Sclerosis

 


P2

Ofatumumab Versus Teriflunomide in Multiple Sclerosis - Supplementary Appendix

 


P3

Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis

 


P3

Ofatumumab – A Potential Subcutaneous B-cell Therapy for Relapsing Multiple Sclerosis

 


P3

Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis

 

Type of content: 
×

Medical Information Request

×

Ask Speakers